Floware Revenue and Competitors
Estimated Revenue & Valuation
- Floware's estimated annual revenue is currently $4.3M per year.
- Floware's estimated revenue per employee is $112,947
Employee Data
- Floware has 38 Employees.
- Floware grew their employee count by 6% last year.
Floware's People
Name | Title | Email/Phone |
---|
Floware Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.1M | 2 | 100% | N/A | N/A |
#2 | $2.4M | 18 | -22% | N/A | N/A |
#3 | $5.5M | 42 | -7% | N/A | N/A |
#4 | $3254.7M | 16033 | N/A | N/A | N/A |
#5 | $0.3M | 4 | N/A | N/A | N/A |
#6 | $3.6M | 31 | -14% | N/A | N/A |
#7 | $0.3M | 4 | N/A | N/A | N/A |
#8 | $0.1M | 1 | 0% | N/A | N/A |
#9 | $1M | 14 | 17% | N/A | N/A |
#10 | $1.2M | 18 | 38% | N/A | N/A |
What Is Floware?
Flo is a productivity tool that combines email, calendars, notes, tasks and contacts in a unique way that simplifies virtually every part of your workflow. Now accepting Beta Testers for Flo iPhone. Also accepting applications for Flo iPad, Flo Mac, and Flo Web.
keywords:N/AN/A
Total Funding
38
Number of Employees
$4.3M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Floware News
2022-04-20 - Overview of Endometriosis
Things like use of birth control pills that reduce menstrual flow are protective. So not using contraceptives, not being pregnant,...
2022-04-20 - Identifying biases in the global placement of river gauges
Stream gauging stations, which measure river flow, are fundamental sources of information for freshwater science.
2022-04-20 - WELL Health keeps $12.00 target at Eight Capital
We continue to believe revenue, Adjusted EBITDA and Shareholder Free Cash Flow are key metrics for shareholders to watch as we expect them...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $4.4M | 38 | N/A | N/A |
#2 | $16.6M | 38 | -42% | N/A |
#3 | $4.2M | 38 | 15% | $10.4M |
#4 | $4.1M | 38 | 12% | N/A |
#5 | $12.3M | 38 | -17% | N/A |